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AbstrAct
This study was designed to examine the expression of hypoxia-inducible factor-
1α (HIF-1α) and the level and activity of endothelial nitric oxide synthase (eNOS) in 
the hearts and livers of mice exposed to hypergravity. Hypergravity-induced hypoxia 
and the subsequent post-exposure reoxygenation significantly increased cardiac HIF-
1α levels. Furthermore, the levels and activity of cardiac eNOS also showed significant 
increase immediately following hypergravity exposure and during the reoxygenation 
period. In contrast, the expression of phosphorylated Akt (p-Akt) and phosphorylated 
extracellular signal-regulated kinase (p-ERK) showed significant elevation only during 
the reoxygenation period. These data raise the possibility that the increase in cardiac 
HIF-1α expression induced by reoxygenation involves a cascade of signaling events, 
including activation of the Akt and ERK pathways. In the liver, HIF-1α expression 
was significantly increased immediately after hypergravity exposure, indicating that 
hypergravity exposure to causes hepatocellular hypoxia. The hypergravity-exposed 
livers showed significantly higher eNOS immunoreactivity than did those of control 
mice. Consistent with these results, significant increases in eNOS activity and nitrate/
nitrite levels were also observed. These findings suggest that hypergravity-induced 
hypoxia plays a significant role in the upregulation of hepatic eNOS. 
INtrODUctION
Hypoxia can stimulate the expression of numerous 
angiogenic factors via induction of hypoxia-inducible 
factor-1 (HIF-1), a heterodimeric protein composed of 
HIF-1α and HIF-1β subunits. Hypoxia results in the 
translocation of HIF-1α to the nucleus, where it binds 
to HIF-1β to form an active complex that initiates 
the transcription of angiogenic factors. While HIF-1α 
expression tightly correlates with cellular oxygen levels, 
it can also be increased or decreased by a variety of 
factors, including cytokines, signaling pathways, genetic 
alterations, and environmental factors. In addition, 
although the role of HIF-1α during hypoxia has been well 
established, the upstream signaling events that stimulate 
HIF-1α expression in response to reoxygenation are yet to 
be characterized.
Hypoxia and reoxygenation activate MEK/ERK and 
PI3K/Akt signaling [1]. In addition, activated ERK and 
Akt pathways have been identified as potent modulators 
of HIF-1α expression [2-6]. Mitogen-activated protein 
kinases (MAPKs) are serine/threonine kinases that 
activates or suppresses a variety of cellular functions, 
including proliferation, differentiation, and apoptosis 
[7, 8]. The extracellular signal-regulated kinase (ERK) 
pathway, which is activated by MAPK/ERK kinase 
(MEK), mediates a number of cellular fates, including 
growth, proliferation, and survival [9, 10]. The serine/
threonine kinase Akt also influences these important 
cellular events and is activated by phosphoinositide 
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3-kinase (PI3K)-dependent signaling pathways [11, 12]. 
Nitric oxide (NO) influences myocardial function 
during physiological and pathological states [13-17]. In 
fact, its role in cardiac hypoxia has become one of the 
most widely investigated topics in basic cardiovascular 
research in recent years. Studies investigating the role of 
NO in cardiac function often report contradictory effects 
(i.e., NO signaling can be harmful or protective) [16]. 
NO is synthesized by NO synthase (NOS), a family of 
isoenzymes with characteristic functional and regulatory 
properties. In the vasculature, NO is produced mostly 
by endothelial NOS (eNOS), which is involved in 
physiological endothelial function and cardiovascular 
homeostasis. Cardiac endothelial cells and ventricular 
cardiomyocytes express eNOS [18-20]. NO production in 
the endothelium is increased or decreased by modulating 
eNOS expression and activity. Several compounds and 
pathophysiological conditions that stimulate or inhibit 
eNOS gene expression have been described. [21]. 
Accumulating evidence suggests that hypoxia results in 
increased cardiac eNOS expression and NO production 
[22, 23]. Some studies have also shown that hypoxic 
ventricular cardiomyocytes produce more intracellular NO 
than normoxic control cells [24-26].
Immunohistochemical studies with antibodies 
against eNOS have localized the enzyme in various cell 
types in many tissues, including the liver [27]. Several 
experimental models of altered hepatic eNOS expression 
have emphasized the crucial role of this enzyme in diverse 
pathophysiological conditions of the liver. For example, 
lipopolysaccharide or lipoteichoic acid treatment of 
an in vivo sepsis model significantly increased eNOS 
mRNA expression [28]. Another study using a model of 
alcoholic liver injury revealed alcohol-related attenuation 
of eNOS activity in rats fed an ethanol-containing liquid 
diet [29]. Furthermore, rats with carbon tetrachloride-
induced cirrhosis exhibit significantly lower hepatic eNOS 
activity than do control animals [30]. eNOS plays a role 
in microcirculatory and immunomodulatory responses 
during hepatic hypoxia/reoxygenation injury. In a mouse 
orthotopic liver transplantation experiment, eNOS-
knockout mice exhibited more severe microcirculatory 
disturbances and hepatocellular necrosis following hepatic 
hypoxia/reoxygenation than their wild-type counterparts 
[31].
The development of a new generation of combat 
aircrafts with extended flight capabilities has raised the 
problem of crew protection against various internal organ 
diseases due to sustained exposure to high gravitational 
(G) force (+Gz). Cardiovascular function is the primary 
pathophysiological target of G forces, which act in the 
same direction as the vascular axis of the sitting pilot. 
G force is a unique stress that principally results in 
impaired coronary blood flow when the inertial vector is 
in the head-foot direction. Previous studies have shown 
that exposure to hypergravity produces marked changes 
in cardiac performance characterized by arrhythmias 
and electrocardiographic abnormalities which probably 
occur as a result of cardiac hypoxia [32, 33]. Changes in 
heart position, distribution of central blood volume, and 
disorders in heart chamber filling decrease the stroke 
volume and consequently reduce cardiac output despite 
tachycardia. This reduced cardiac output decreases 
coronary blood flow and results in hypoxic insult to the 
heart. Furthermore, exposure to +Gz severely decreases 
blood flow to the abdominal organs, including the 
spleen, pancreas, kidneys and liver—an apparent effort 
to maintain blood flow to the brain and heart [34, 35]. It 
is likely that the changes in visceral blood flow are the 
result of some combination of hypergravity-induced 
cardiovascular reflex response and emotional stress.
The effects of exposure to hypergravity on 
cardiovascular function have been the subject of numerous 
studies. However, the field is lacking crucial information 
regarding potential changes in HIF-1α, ERK, Akt, and 
eNOS expression in heart tissue following hypergravity 
exposure. Moreover, no information is available on 
alterations in hepatic eNOS expression and activity 
following hypergravity exposure. This study was designed 
to investigate whether hypergravity exposure alters cardiac 
HIF-1α levels and/or hepatic eNOS expression and activity 
and activates the ERK and/or Akt pathways.
rEsULts
HIF-1α expression in hypergravity-exposed hearts
The expression of cardiac HIF-1α was examined to 
confirm that hypergravity induces hypoxia in the hearts 
of centrifuged mice. HIF-1α expression was significantly 
elevated immediately after centrifugation (Figure 1A), 
indicating that hypergravity exposure induces cardiac 
hypoxia. Unexpectedly, HIF-1α levels further increased 
from 1 to 3 hr post-exposure. After a slight decrease at 
6 hr post-exposure, HIF-1α levels decreased further to 
the level in the control group. We next analyzed HIF-1α 
mRNA levels to determine whether the changes in HIF-1α 
levels were the result of increased transcription or protein 
stability. No significant changes in HIF-1α mRNA were 
observed, indicating that hypergravity exposure altered 
HIF-1α levels independent of transcription of the HIF-1α 
gene (Figure 1B).
p-ERK and p-Akt expression in hypergravity-
exposed hearts
The levels of phosphorylated ERK (p-ERK) and 
phosphorylated Akt (p-Akt) increased significantly from 
1 to 3 hr post-exposure, but were unchanged immediately 
after centrifugation. The levels of p-ERK (P = 0.007) 
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and p-Akt (P = 0.009) in hearts of the 1 hr-interval group 
were 4.3- and 3.6-fold the levels in the control group, 
respectively. Moreover, the highest cardiac p-ERK and 
p-Akt expression was observed 3 hr post-exposure. The 
levels of cardiac p-ERK (P = 0.002) and p-Akt (P = 
0.004) in the 3 hr-interval group were 6.8- and 5.7-fold 
the levels in the control group, respectively. After 6 hr 
post-exposure, cardiac p-ERK and p-Akt levels were not 
significantly different from those of the control group 
(Figure 1C).
eNOS expression in hypergravity-exposed hearts
Quantitative analysis of eNOS protein expression 
(Figure 2A) revealed a significant increase immediately 
after the end of centrifugation (P = 0.006), which persisted 
until 3 hr post-exposure. The highest eNOS level was 
observed at 3 hr post-exposure (P < 0.001) and resulted in 
a double peak expression pattern. eNOS levels decreased 
to that of the control group throughout the remainder of 
the post-exposure period.
eNOS activity in hypergravity-exposed hearts
We measured the conversion of [14C]-labeled 
L-arginine to L-citrulline in cardiac tissue homogenates 
to quantify eNOS activity. Our results revealed a 
concordance between eNOS activity and protein 
expression: cardiac eNOS activity was significantly 
elevated immediately after exposure to hypergravity (P = 
0.026), increased further from 1 (P = 0.019) to 3 hr (P = 
0.008) post-exposure, and returned to baseline levels at 12 
hr post-exposure (Figure 2B).
Nitrate/nitrite levels in hypergravity-exposed 
hearts
Cardiac nitrate/nitrite levels showed a trend similar 
to that of eNOS expression and activity (Figure 2B). 
Nitrate/nitrite levels in cardiac tissue homogenates were 
significantly elevated immediately after exposure to 
hypergravity (P = 0.005). After a slightly decrease 1 hr 
Figure 1: Effect of exposure to hypergravity on cardiac expression of HIF-1α, p-Akt, and p-ERK. A. Western blotting 
detected HIF-1α as a 120-kDa band, the levels of which increased immediately after centrifugation. This increase persisted until 6 hr post-
centrifugation. Afterwards, protein levels returned to basal levels. B. Quantitative RT-PCR analysis revealed no significant alterations in 
mRNA levels of HIF-1α during hypoxia or reoxygenation. C. In contrast to HIF-1α and eNOS, elevated p-Akt and p-ERK expression was 
observed during the reoxygenation period (1-3 hr), but not immediately after hypoxia (0 hr). **P < 0.01.
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post-exposure, the levels peaked at 3 hr post-exposure (P 
= 0.001), but subsequently decreased to eventually reach 
values even lower than those of the control group at 24 hr 
post-exposure. 
Histopathology of hypergravity-exposed hearts
Representative photomicrographs are shown 
in Figure 3. Hearts of the control group displayed no 
pathologic abnormality. Hearts from the centrifuged mice 
did not show any significant abnormalities or significant 
differences in cardiomyocyte size and morphology 
compared with the control group. In a few areas, the 
cardiac muscle fibers of hypergravity-exposed hearts 
appeared separated from each other with foci of mininal 
myofiber disorganization, and the individual muscle 
fibers appeared slightly smaller in diameter compared 
with that of the control group. In all specimens, there 
Figure 2: Effect of exposure to hypergravity on cardiac eNOS protein expression and enzymatic activity and NO 
production. A. Significantly elevated eNOS protein levels were observed from 1 to 3 hr post-exposure, with two peaks noted between 
0 and 3 hr post-exposure. B. An L- [14C]-citrulline assay and a nitrate/nitrite assay showed similar trends in the levels of eNOS enzymatic 
activity and nitrate/nitrite concentration, both of which significantly increased from 0 hr to 6 hr post-exposure. Both parameters reached a 
peak at 3 hr post-exposure. *P < 0.05; **P < 0.01; ***P < 0.001.
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was no definitive myocellular necrosis, compensatory 
hypertrophy or interstitial fibrosis. No significant 
inflammatory response was detected in the tissue of the 
myocardium or endocardium, except for occasional 
isolated neutrophils or lymphocytes, which were 
extravasated from the blood vessels.
HIF-1α expression in hypergravity-exposed 
livers
HIF-1α expression was examined to confirm 
that hypergravity induces hypoxia in the livers of 
centrifuged mice. HIF-1α levels increased significantly 
immediately after hypergravity exposure (P = 0.007; 
Figure 4A), indicating that hypergravity induces 
hepatocellular hypoxia. HIF-1α levels decreased to 
the basal level found in the control group at 1 hr post-
exposure and these levels were maintained throughout 
the remainder of the post-exposure period.
eNOS expression in hypergravity-exposed 
livers
Quantitative analysis of eNOS mRNA expression 
revealed a 3.3-fold increase in the amount of eNOS 
mRNA at 0 hr post-exposure (Figure 4B; P = 0.015). 
Subsequently, the mRNA levels fell rapidly to basal 
levels. Throughout the remainder of the post-exposure 
period, eNOS mRNA levels were maintained at those 
found in the control group.
Immunohistochemical staining revealed a 
significant increase in eNOS expression in the livers 
of centrifuged mice (Figure 5A). The presence 
of hepatocytes, labeled intensely in brown, in the 
experimental groups indicated that eNOS expression 
was upregulated following hypergravity exposure, 
and this early rise persisted up to 6 hr post-exposure. 
The control group showed no eNOS expression in 
the cytoplasm of the hepatocytes, although there 
was a sharp demarcation of bile canaliculi by eNOS. 
In contrast, mice exposed to hypergravity showed 
cytoplasmic eNOS immunoreactivity, although the 
intensity and proportion were uneven. The 0-hr 
interval group showed weak-to-moderate eNOS 
immunoreactivity in the cytoplasm of some pericentral 
(zone 3) hepatocytes. In the 1-hr interval group, a 
greater number of eNOS-positive hepatocytes showed 
high staining intensity than that in the 0-hr interval 
group. In the 3- and 6-hr interval groups, the number 
of eNOS-positive hepatocytes clearly increased, 
and most cells exhibited high staining intensity. The 
12-hr interval group showed a decreased number 
of eNOS-positive hepatocytes, with faint-to-weak 
staining intensity. In addition, there was a unique 
distribution of eNOS-positive hepatocytes according 
to the time course (Figure 5B). The control group 
showed no staining within hepatocytes. In contrast, 
the representative eNOS staining patterns in the 
0-hr interval group revealed mild eNOS expression, 
limited to the pericentral hepatocytes around medium-
sized vessels. The 3- and 6-hr interval groups 
displayed strong eNOS expression in transitional 
(zone 2) hepatocytes and in perivascular hepatocytes 
surrounding large-sized central veins.
eNOS activity in hypergravity-exposed livers
To quantify hepatic eNOS activity, we measured 
the conversion of [14C]-labeled L-arginine to 
L-citrulline in liver tissue homogenates. The results 
revealed concordance between eNOS activity and 
protein expression. Hepatic eNOS activity increased 
significantly immediately after exposure (P = 0.019), 
was maintained at significantly elevated levels from 
1 (P = 0.026) to 3 hr (P = 0.028) post-exposure, and 
Figure 3: Representative photomicrographs of tissue sections obtained from hypergravity-exposed hearts. In all 
specimens, there was no definitive myocellular necrosis, compensatory hypertrophy or interstitial fibrosis. No significant inflammatory 
response was detected in the tissue of the myocardium.
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returned to baseline levels at 12 hr post-exposure 
(Figure 6).
Nitrate/nitrite levels in hypergravity-exposed 
livers
Hepatic nitrate/nitrite levels showed a trend 
similar to those of eNOS expression and activity 
(Figure 6). Nitrate/nitrite levels in liver tissue 
homogenates increased significantly immediately 
after exposure to hypergravity (P = 0.016). After 
a slight decrease at 1 hr post-exposure, the levels 
began decreased further up to 3 hr post-exposure, 
and continued to fall until they reached values similar 
to those of the control group at 12 hr post-exposure. 
None of the animals displayed remarkable behavioral 
changes during or after centrifugation.
Histopathology of hypergravity-exposed livers
Representative photomicrographs are shown in 
Figure 7. The centrifuged mice showed no significant 
alterations in the size, shape or weight of their livers. 
No significant increase in fibrous connective tissue 
was observed in the centrifuged livers. There was no 
significant morphological changes in the centrifuged 
livers in comparison with those of the control group. 
The sinusoids were well preserved. No evidence of 
hepatocellular necrosis, hyperemia, hemorrhage or 
advanced degenerative change was detected.
DIscUssION
In this study, we found that cardiac HIF-1α levels 
significantly increase immediately after hypergravity 
exposure, and remain high until 6 hr post-exposure 
when oxygen tension is normal. A biphasic pattern 
of HIF-1α induction was observed (i.e., after hypoxia 
and during reoxygenation). In contrast, HIF-1α mRNA 
levels were not significantly altered after hypergravity 
exposure or during the reoxygenation period. These 
results indicate that cardiac HIF-1α accumulates during 
both hypoxia and reoxygenation and that its expression 
is regulated mainly at the protein level.
HIF-1α levels were elevated during 
reoxygenation as the result of increased protein 
synthesis and/or stabilization since we did not observe 
significant changes in HIF-1α mRNA levels. HIF-1α 
can be detected under normoxic conditions in response 
to stimulation by various growth factors, hormones, and 
cytokines [36]. Activation of the PI3K/Akt signaling 
pathway can lead to increased protein translation and is 
a major mechanism of normoxic HIF-1α upregulation 
[37]. In addition, HIF-1α protein synthesis during 
reoxygenation is known to correlate with activation 
of the MEK/ERK pathway [38]. Consistent with these 
data, we found that p-Akt and p-ERK levels increased 
significantly during the 1 to 3 hr of reoxygenation, 
whereas their levels were not elevated under hypoxia. 
The level of p-Akt and p-ERK returned to basal 
values after 6 hr of reoxygenation. These results are 
in agreement with previous studies demonstrating that 
Akt and ERK become transiently activated during 
Figure 4: Effects of exposure to hypergravity on hepatic expression of HIF-1α and eNOS mRNA. A. HIF-1α expression 
increased significantly in the livers of the centrifuged mice immediately after exposure to hypergravity. This transient rise and rapid 
decrease were concordant with B. significantly elevated eNOS mRNA levels, which were observed at 0 hr post-exposure only. *P < 0.05; 
**P < 0.01.
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the early phase of reoxygenation following hypoxia 
[1, 39]. Our result for the simultaneous upregulation 
of HIF-1α, p-Akt, and p-ERK supports the hypothesis 
that transient activation of ERK and Akt pathways 
may be involved in increasing cardiac HIF-1α levels 
during reoxygenation. It is also reasonable to speculate 
that the Akt and ERK pathways influence HIF-1α 
stability. Further investigation is required to identify 
the downstream effectors of Akt and ERK activation 
in reoxygenation.
In this study, the protein level and activity of 
eNOS were significantly increased immediately after 
exposure to hypergravity and during the reoxygenation 
period. These results were concordant with the time-
dependent alteration of cardiac NO production 
after hypergravity exposure. Although the precise 
mechanism by which hypergravity causes upregulation 
of the cardiac eNOS/NO system is unknown, there are 
several possible explanations. First, previous studies 
have reported on the subcellular biochemical and 
ultrastructural alterations in the hearts of experimental 
animals exposed to hypergravity, indicating that +Gz 
stress could cause hypoxic myocardial insult [40-
42]. Indeed, hypoxia has been associated with eNOS 
upregulation. Given that the body regularly deals with 
a wide range of oxygen tensions based on the demands 
of specific tissues, it is not surprising that the vascular 
beds of various organs should respond differently to 
Figure 5: Distinctive hepatocellular eNOS immunostaining pattern induced by exposure to hypergravity. A. Alteration 
in hepatic eNOS immunostaining intensity and proportion following exposure to hypergravity. The control group showed no cytoplasmic 
eNOS immunoreactivity in hepatocytes, except a clear demarcation of bile canaliculi by eNOS. In contrast, the 0-hr interval group 
showed weak-to-moderate eNOS immunoreactivity in the cytoplasm of some pericentral hepatocytes. In the 1-hr interval group, the 
number of eNOS-positive hepatocytes with moderate to strong intensity increased significantly. The 3- and 6-hr interval groups revealed 
a significantly higher proportion of eNOS expression than the 0- or 1-hr interval groups. Furthermore, most cells exhibited strong eNOS 
expression intensity. The 12-hr interval group showed weak cytoplasmic eNOS immunoreactivity in a few pericentral hepatocytes. B. 
Unique distribution of hepatic eNOS immunoreactivity in hypergravity-exposed mice. No cytoplasmic eNOS expression was observed in 
the hepatocytes of the control group. The 0-hr interval group exhibited eNOS expression limited to the pericentral (zone 3) hepatocytes 
around medium-sized vessels. The 3- and 6-hr interval groups displayed strong eNOS expression in the transitional (zone 2) hepatocytes, 
as well as in the perivascular hepatocytes surrounding large-sized central veins.
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hypoxia, depending on their specific in vivo and in vitro 
milieus. Arnet et al. [43] found that hypoxia induces the 
upregulation of eNOS in the aorta. Justice et al. [22] 
also demonstrated that hypoxia causes a time-dependent 
increase in the level of eNOS in coronary microvessels. 
Xu et al. [23] reported that eNOS regulation is sensitive to 
oxygen tension and that hypoxia significantly stimulates 
eNOS activity in coronary arterioles. Moreover, Depre 
et al. [25] showed that cardiac eNOS is rapidly activated 
by hypoxia and that the increased eNOS activity is 
maintained during the entire hypoxic episode. Together 
with these data, our findings support the notion that 
hypergravity-induced cardiac hypoxia upregulates eNOS 
expression. Second, regarding the sustained upregulation 
of eNOS during the 1-3 hr post-centrifugation period, 
many studies have indicated a cardioprotective role for 
NO produced by eNOS in cardiac reoxygenation injury. 
Brunner et al. [44] and Jones et al. [45] demonstrated that 
eNOS overexpression increases myocardial tolerance to 
reoxygenation, as reflected by the improved left ventricular 
pressure and reduced infarct size. Furthermore, a study 
using an eNOS-knockout mouse model demonstrated 
that the loss of eNOS strongly exacerbated myocardial 
reoxygenation injury following hypoxia [46]. eNOS loss 
has also been shown to aggravate hypoxia/reoxygenation 
injury [47]. We speculate that reoxygenation injury 
might occur when the blood supply returns to the heart 
after a period of hypoxia due to +Gz exposure and that 
the increased eNOS levels and activity might induce 
NO production to protect the myocardium against 
reoxygenation injury. It is well documented that jet fighter 
pilots are repeatedly exposed to high +Gz. Under such 
circumstances, blood is pushed in the direction associated 
with the G force. It is therefore possible that the oxygen 
supply to heart muscle decreases to a level below that 
of the demand, subjecting the myocardium to hypoxia/
reoxygenation injury. eNOS upregulation may play a 
protective role in such situations. Further investigations 
are necessary to elucidate the mechanism of eNOS 
upregulation following hypergravity exposure.
Previous studies have suggested that the Akt and 
ERK pathways are involved in eNOS activation. Fulton 
et al. [48] demonstrated that Akt directly phosphorylates 
eNOS, thereby enhancing eNOS activity and NO 
production. These results link signal transduction by 
Akt to NO release. Similarly, p-Akt has been shown to 
phosphorylate and activate eNOS [49]. These data suggest 
that phosphorylation by Akt is critical for eNOS activation. 
The relationship between eNOS and the ERK pathway is 
an area of active investigation. eNOS and ERK physically 
Figure 6: Effects of exposure to hypergravity on the expression of eNOS enzymatic activity of and NO production. 
L- [14C]-citrulline and nitrate/nitrite assays showed similar trends in the levels of eNOS enzymatic activity and nitrate/nitrite concentration, 
both of which significantly increased from 0 hr to 1 hr (eNOS activity) or 3 hr (nitrate/nitrite level) post-exposure. Both parameters peaked 0 
hr post-exposure. Results are mean values of three independent experiments in each animal. This increase persisted for 24 hr post-exposure. 
*P < 0.05.
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associate in the cytoplasm [50], and ERK appears to 
promote eNOS activity [51]. Liu et al. [49] reported 
that PD-098059, an MEK inhibitor and a downstream 
inactivator of ERK, abolishes eNOS phosphorylation and 
NO generation, suggesting a crucial role for ERK in the 
upregulation of the eNOS/NO system. Our observation of 
the co-expression of eNOS, p-ERK, and p-Akt raises the 
possibility that eNOS upregulation during reoxygenation 
may be partly mediated by the activation of the Akt and 
ERK pathways.
Goldstein et al. [52] reported the effects of 
hypergravity on cardiac morphology. After exposure 
to +2Gz for 14 d, the hearts of centrifuged rats showed 
regional heterogeneous myofibers, nuclear edema, and 
binucleation and no myocyte necrosis. In contrast, we 
did not find any histopathological lesions in the hearts 
of centrifuged mice. Unlike the hypergravity exposure 
protocol used by Goldstein et al., our protocol used a 
rather short duration of exposure (1 hr) and a slightly 
higher G force (+3Gz vs. +2Gz). It may also be possible 
that hypergravity per se is not the direct cause of tissue 
hypoxia [53]. Instead, the responses to hypergravitational 
forces may be an attempt to prevent myocardial infarction 
and stroke due to possible subsequent ischemic stresses. 
Further investigations are necessary to clarify the precise 
mechanism by which hypergravity exposure leads to 
alterations in cardiac morphology.
We report here the first quantification of eNOS 
expression in the livers of mice exposed to hypergravity. 
Real-time RT-PCR analysis and immunohistochemical 
staining revealed that eNOS expression increased 
significantly immediately after hypergravity exposure. The 
early rise in hepatic eNOS levels was concordant with HIF-
1α upregulation and eNOS activity. These results suggest 
that exposure to hypergravity induces hepatocellular 
hypoxia and has a significant effect on eNOS expression 
and activity in mouse liver. In addition, we observed 
that the livers of hypergravity-exposed mice exhibited a 
significant increase in eNOS immunoreactivity. Increased 
cytoplasmic eNOS expression was observed immediately 
after cessation of centrifugation and persisted for 6 hr 
post-exposure, whereas no cytoplasmic eNOS expression 
was observed in the hepatocytes of the controls. Although 
the precise mechanism by which exposure to hypergravity 
leads to upregulation of hepatic eNOS is unknown, there 
are some possible explanations. The reflex cardiovascular 
responses to hypergravity include tachycardia and 
increase in total peripheral vascular resistance resulting 
from increase in sympathetic vascular tone. Laughlin et 
al. [34] suggested that the marked reduction in hepatic 
blood flow during exposure to hypergravity is the result 
of sympathetic vasoconstriction in visceral vascular beds. 
Based on these data, we hypothesized that hepatocellular 
hypoxia due to hypergravity-induced inadequate hepatic 
blood flow might be attributable to eNOS upregulation. 
The post-exposure increase in HIF-1α supports our 
hypothesis. Furthermore, this hypothesis is also supported 
by a recent study demonstrating that tissue hypoxia 
upregulates hepatic eNOS in rats exposed to 10% oxygen 
[54]. Previous studies suggested that hypoxia is associated 
with upregulation of eNOS mRNA expression [23, 43, 
55]. In this study, we observed weak-to-moderate eNOS 
expression in some pericentral hepatocytes of the 0-hr 
interval group, followed by stronger and more frequent 
eNOS immunoreactivity in transitional hepatocytes of the 
3- and 6-hr interval groups. These findings suggest that 
hypergravity-induced hepatocellular alterations began in 
zone 3 and extended to the surrounding hepatocytes over 
time. The area most susceptible to hypoxic hepatocellular 
injury is zone 3 of the hepatic acini because blood flows 
through this zone last. Pericentral hepatocytes receive the 
least oxygenation and are the first to be affected during 
times of hypoxia. Based on the greater susceptibility 
of this area of the liver to hypoxic injury, the unique 
distribution of eNOS expression found here supports 
our hypothesis that hypergravity-induced hepatocellular 
hypoxia might cause eNOS upregulation.
Additionally, the possibility that the increase in 
eNOS expression might be caused by hepatic reperfusion 
injury cannot be excluded. Hypergravity-induced 
Figure 7: Representative photomicrographs of tissue sections obtained from hypergravity-exposed livers. The centrifuged 
mice showed no significant morphological changes in comparison with those of the control group.
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hepatocellular hypoxia seems insufficient to explain 
the sustained upregulation of eNOS expression up to 
3-6 hr post-exposure. We hypothesized that reperfusion 
injury might occur when the blood supply has returned 
to the liver after a period of hypoxia due to hypergravity 
exposure and that this reperfusion injury might induce 
eNOS upregulation. These hypotheses are supported by 
previous data showing that reperfusion after ischemia 
induces a marked increase in eNOS expression in liver 
tissue [56, 57]. eNOS plays a hepatoprotective role in the 
post-ischemic liver by inhibiting cytokines and oxidant 
release by Kupffer cells [58, 59]. Furthermore, a growing 
body of evidence from experimental studies substantiates 
the beneficial effects of eNOS in ameliorating hepatic 
reperfusion injury [60]. Duranski et al. [56] demonstrated 
that eNOS overexpression significantly attenuates hepatic 
tissue injury after ischemia followed by reperfusion. 
Kawachi et al. [61] observed significant enhancement of 
hepatic tissue injury in eNOS-deficient mice subjected 
to ischemia-reperfusion compared with wild-type 
mice. In addition, Theruvath et al. [31] revealed that 
eNOS-deficient liver grafts exhibit decreased sinusoidal 
blood flow velocity and exacerbated reperfusion injury 
(indicated by increases apoptosis and necrosis, disrupted 
microcirculation, and enhanced graft infiltration by 
leukocytes) when compared with the transplanted livers 
of wild-type mice. In conjunction with these data, our 
findings raise the possibility that eNOS upregulation 
during hypergravity exposure might be a defense 
mechanism to protect the liver from further damage due to 
ischemia-reperfusion. Further investigations are necessary 
to clarify the precise mechanism by which hypergravity 
alters hepatic eNOS expression.
In conclusion, this study is the first to describe 
hypergravity-induced alterations in the expression of 
cardiac HIF-1α and eNOS. We observed a significant up-
regulation in the levels of HIF-1α and eNOS in the hearts 
of hypergravity-exposed mice immediately after exposure 
and during the post-exposure reoxygenation period. In 
addition, we found that p-Akt and p-ERK expression was 
significantly elevated during the reoxygenation period, 
but not immediately after hypergravity exposure. Our 
results raise suggest that upregulation of HIF-1α and 
eNOS during reoxygenation may be partly mediated 
by activation of the Akt and ERK pathways. We also 
observed significant upregulation of eNOS expression and 
activity in the livers of hypergravity-exposed mice that 
persisted for 3-6 hr post-exposure. These results suggest 
that hypergravity exposure has a significant effect on the 
upregulation of eNOS in mouse liver. However, further 
investigations are necessary to confirm or disprove our 
findings and clarify the precise mechanism by which 
hypergravity alters hepatic eNOS expression.
MATERIALS AND METHODS
Experimental animals and hypergravity exposure
ICR mice at 7 weeks of age were purchased from 
Samtako Bio Korea Co., Ltd. (Osan-si, Gyeonggi-do, 
Republic of Korea). Throughout the experimental period, 
animals were fed standard laboratory mouse chow, 
provided with free access to water, and maintained on a 
12-hour light-dark cycle under pathogen-free conditions 
with temperature and moisture levels controlled at 20°C to 
25°C and 40% to 45%, respectively. Mice were exposed to 
short-term hypergravity at +3Gz for 1 hr using an animal 
centrifuge. In the centrifuge, mice were placed inside 
a cylindrical plastic restraint, which allowed +Gz to be 
delivered along the rostro-caudal axis. After mice were 
secured, the restraint was placed into the animal centrifuge, 
and a cage-mounting module was attached at the end 
of the arm, which allowed for one degree of freedom to 
ensure that the net +Gz field was perpendicular to the floor 
of the restraint device. The control group was treated in an 
environment identical to that of the centrifuged group with 
the exception of the +3Gz exposure. The behavior of the 
mice was monitored with a CCD camera throughout the 
centrifugation experiments. The Institutional Animal Care 
and Use Committee of the Republic of Korea Air Force 
Aerospace Medical Center approved all experimental 
procedures involving the animals.
To investigate the time course of protein and/or 
mRNA expression, the centrifuged mice were randomly 
divided into six groups containing nine to 12 animals per 
group. At 0, 1, 3, 6, 12, and 24 hr post-exposure, mice 
were sacrificed by cervical dislocation and laparotomized 
via a midline incision. Heart and liver tissues were 
immediately removed, preserved in a 10% formaldehyde 
solution, snap-frozen in liquid nitrogen, and stored at 
-70°C until further analysis.
Western blotting
Tissue samples were homogenized in lysis 
buffer (50 mM Tris, pH 7.5, 1% Nonidet P-40, 2 mM 
ethylenediaminetetraacetic acid, 10 mM sodium chloride, 
20 μg/mL aprotinin, 20 μg/mL leupeptin and 1 mM 
phenylmethylsulfonyl fluoride) at a volume of 1 mL 
per 100 mg tissue, and placed on ice for 20 min. After 
centrifugation at 13000 rpm for 20 min, the supernatant 
was collected and used for immunoblotting. Immunoblots 
were incubated with anti-HIF-1α antibody (1:500; Novus 
Biologicals, LLC, Littleton, CO, USA) or anti-GAPDH 
antibody (1:800; Novus Biologicals, LLC) followed 
by incubation with horseradish peroxidase-conjugated 
secondary antibody (Cell Signaling Technology, Beverly, 
MA, USA). Protein bands were visualized using an 
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enhanced chemiluminescence reagent (Amersham 
Biosciences, Buckinghamshire, UK) according to the 
manufacturer’s protocol.
Quantitative real-time reverse transcriptase-
polymerase chain reaction analysis
Total RNA was isolated using the NucleoSpin RNA 
II extraction kit (Macherey-Nagel GmbH & Co. KG, 
Dueren, Germany) and used for cDNA synthesis with a 
ReverTra Ace-α- reverse transcriptase kit (Toyobo Co., 
Ltd., Osaka, Japan); both kits were used according to 
the manufacturers’ instructions. The amount of standard 
cDNA was determined photometrically. The cDNA was 
used for real-time reverse transcriptase-polymerase chain 
reaction (RT-PCR) using SsoAdvanced SYBR Green 
Supermix (Bio-Rad Laboratories, Inc., Hercules, CA, 
USA). PCR was performed using the Bio-Rad CFX96 
Real-Time PCR Detection System (Bio-Rad Laboratories, 
Inc.) with a C1000 Thermal Cycler (Bio-Rad Laboratories, 
Inc.). PCR reactions for HIF-1α, eNOS, and GAPDH 
were initiated with a denaturing step at 95°C for 3 min, 
followed by 40 cycles at 95°C for 10 sec, 58°C for 10 
sec, and 72°C for 20 sec. A melting curve (ramping from 
65°C to 95°C) was performed following RT-PCR to test 
for the presence of primer dimers. When primer dimer 
formation was detected, the PCR was repeated using a 
separate cDNA aliquot. Each measurement was repeated 
three times, and the values were used to calculate the ratio 
of HIF-1α to GAPDH, with the control set at a value of 1.0 
to serve as a standard.
Enzyme-linked immunosorbent assay
Lysates were prepared from tissue samples as 
described above. The protein concentrations of HIF-
1α, p-Akt, p-ERK, and eNOS were determined using 
commercially available enzyme-linked immunosorbent 
assay (ELISA) kits (R&D Systems, Inc., Minneapolis, 
MN, USA).
Histopathology
Hearts and livers from the control and treated 
animals were immediately preserved in a 10% 
formaldehyde solution. After 48 to 72 hours of formalin 
fixation, the tissues were dissected and processed for 
routine hematoxylin and eosin staining to assess general 
architecture and injury.
Immunohistochemistry
eNOS protein expression was assessed by 
immunohistochemical staining using the Bond 
Polymer Intense Detection System (Vision Biosystems, 
Mount Waverley, Victoria, Australia) according to 
the manufacturer’s instructions. To summarize, 4-μm 
sections of formalin-fixed, paraffin-embedded tissue 
were deparaffinized with Bond Dewax Solution (Vision 
BioSystems), and antigen retrieval was performed 
using Bond ER Solution (Vision BioSystems) for 30 
min at 100°C. Endogenous peroxidases were quenched 
by incubating sections in hydrogen peroxide for 5 min. 
Sections were then incubated for 15 min at ambient 
temperature with a rabbit polyclonal anti-eNOS antibody 
(1:100; Abcam, Cambridge, MA, USA). The biotin-
free polymeric horseradish peroxidase-linker antibody-
conjugate system was used in the Bond-maX automatic 
slide stainer (Vision BioSystems), and visualization 
was performed using a 3.3-diaminobenzidine (DAB) 
solution (1 mM DAB, 50 mM Tris-HCl buffer [pH 




). Nuclei were counterstained 
with hematoxylin. Slides were subsequently dehydrated 
following a standard procedure and sealed with coverslips. 
To minimize inter-assay variation, positive and negative 
control samples were included in each run. The positive 
control sample was normal liver tissue, while the negative 
control was prepared by substituting non-immune serum 
for the primary antibody. No staining was detected.
L- [14C]-Citrulline formation assay to measure 
NOS activity
Tissue samples were ground to a fine powder in 
liquid nitrogen and homogenized in a solution containing 
10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (pH 7.2), 0.32 M sucrose, 0.1 mM 
ethylenediaminetetraacetic acid, 1 mM dithiothreitol, 
and protease inhibitors (10 μg/mL each of leupeptin, 
pepstatin A, chymostatin, antipain, and soybean trypsin 
inhibitor, and 100 μg/mL phenylmethylsulfonyl fluoride). 
The homogenate was centrifuged and the supernatants 
were incubated at 37°C for 60 min with the following: (a) 
assay cocktail: 2 μM L- [14C]-arginine (General Electric 
Healthcare, Milwaukee, WI, USA), 18 μM L-arginine, 1 
mM L-citrulline, 50 mM L-valine, 1 mM dithiothreitol, 
0.1 mM NADPH, 0.1 mM tetrahydrobiopterin, 1 mM 
magnesium chloride, 0.2 mM calcium chloride, and 50 
mM potassium hydrogen phosphate, pH 7.2 (Sigma-
Aldrich, St. Louis, MO, USA); (b) cocktail with 1 mM 
ethylene glycol tetraacetic acid (EGTA); or (c) cocktail 
with 1 mM EGTA plus 1 mM L-NG-monomethyl-L-
arginine, monoacetate salt, to differentiate Ca2+-dependent 
eNOS activity from Ca2+-independent inducible NOS 
activity. NOS activity was quantified by measuring l- 
[14C]-citrulline with a liquid-scintillation counter (Wallac 
1410, Pharmacia LKB Biotechnology AB, Uppsala, 
Sweden), following removal of unreacted l- [14C]-arginine 




NO production was indirectly quantified by 
measuring the amount of nitrate/nitrite in supernatants 
from heart homogenates using a Nitrate/Nitrite 
Colorimetric Assay Kit (Cayman Chemicals, Ann Arbor, 
MI, USA) following the manufacturer’s instructions. 
Briefly, 5 μL aliquots were injected into a Sievers Nitric 
Oxide Analyzer (NOA 280i; Sievers Instruments, Boulder, 
CO, USA) and pelleted by centrifugation with acetic 
acid as a reductant for nitrite, and vanadium chloride 
and hydrogen chloride as reductants for nitrate and 
sodium iodide. The values were normalized for protein 
concentration as assessed via Bradford reagent. Nitrate/
nitrite concentration was expressed as μM based on tissue 
weight.
Statistical analysis
All values are provided as mean ± standard error. 
Differences in the normalized mRNA ratio, protein 
concentration, enzymatic activity, and nitrite/nitrate 
concentration between the groups were assessed using a 
Student’s t-test (SPSS ver. 18.0 software; IBM SPSS Inc., 
Chicago, IL, USA), and P values < 0.05 were considered 
statistically significant.
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